Cargando…
Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy
Galectins are a family of ß-galactoside-binding proteins that play a variety of roles in normal physiology. In cancer, their expression levels are typically elevated and often associated with poor prognosis. They are known to fuel a variety of cancer progression pathways through their glycan-binding...
Autores principales: | Lau, Lee Seng, Mohammed, Norhan B. B., Dimitroff, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778980/ https://www.ncbi.nlm.nih.gov/pubmed/36555198 http://dx.doi.org/10.3390/ijms232415554 |
Ejemplares similares
-
Macrophages in immunoregulation and therapeutics
por: Chen, Shanze, et al.
Publicado: (2023) -
Immunoregulation of macrophages by dynamic ligand presentation via ligand–cation coordination
por: Kang, Heemin, et al.
Publicado: (2019) -
Galectin-Glycan Interactions as Regulators of B Cell Immunity
por: Giovannone, Nicholas, et al.
Publicado: (2018) -
The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
por: Wang, Meiqi, et al.
Publicado: (2023) -
Exosomes for Immunoregulation and Therapeutic Intervention in Cancer
por: Zhang, Xuan, et al.
Publicado: (2016)